Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.

about

Comparative analysis of neutropenia in patients receiving prolonged treatment with ceftaroline.

P2860

Q54301713-0183CE91-D11A-46FE-9847-449805108046

P2860

Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.

Item

http://www.wikidata.org/entity/Q38987098

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Ceftaroline Fosamil: A Review ...... Community-Acquired Pneumonia.

@en

type

Item

label

Ceftaroline Fosamil: A Review ...... Community-Acquired Pneumonia.

@en

prefLabel

Ceftaroline Fosamil: A Review ...... Community-Acquired Pneumonia.

@en

P1476

Ceftaroline Fosamil: A Review ...... Community-Acquired Pneumonia.

@en

P2860

Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections

Methicillin-resistant Staphylococcus aureus therapy: past, present, and future

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.

In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.

World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections

Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections.

Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing.

Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolates

P2888

s40265-016-0654-4

P304

1659-1674

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-016-0654-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lesley J Scott

P577

2016-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037740129

http://www.w3.org/2001/XMLSchema#string

P698

27766567

http://www.w3.org/2001/XMLSchema#string

P921

Bruschtfiewer

Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.

about

P2860

P2860

Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.

description

name

type

label

prefLabel

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921